Real-World Use of BTK Inhibitors in Chronic Lymphocytic Leukemia
Marc S. Hoffmann, MD, and Mazyar Shadman, MD, MPH, discuss the real-world use of BTK inhibitors for patients with chronic lymphocytic leukemia.
Marc S. Hoffmann, MD, and Mazyar Shadman, MD, MPH, discuss the real-world use of BTK inhibitors for patients with chronic lymphocytic leukemia.
